Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder

PURPOSE/BACKGROUND: Major depressive disorder (MDD) and obesity commonly co-occur. We sought to assess the impact of Body Mass Index (BMI) on the acute antidepressant effects of ketamine in patients with treatment resistant depression (TRD). METHODS/PROCEDURES: Post-hoc analyses were conducted from...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Psychopharmacol
Main Authors: Freeman, Marlene P., Hock, Rebecca S., Papakostas, George I., Judge, Heidi, Cusin, Cristina, Mathew, Sanjay J., Sanacora, Gerard, Iosifescu, Dan V., DeBattista, Charles, Trivedi, Madhukar H., Fava, Maurizio
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185034/
https://ncbi.nlm.nih.gov/pubmed/32332464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000001209
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados